Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiro Okami

Showing results (161-170 of 166) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 166 results.
The American Journal of Surgical Pathology|March 23, 2022
Thymic Mucoepidermoid Carcinoma: A Clinicopathologic and Molecular StudyTakayuki Murase, Satsuki Nakano, Tadashi Sakane, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 24, 2023
Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607LTomohiro Maniwa, Jiro Okami, Tomohiro Miyoshi, et al.
The Lancet. Respiratory Medicine|March 9, 2023
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trialKeiju Aokage, Kenji Suzuki, Hisashi Saji, et al.
Respiratory Research|July 25, 2016
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)Takekazu Iwata, Ichiro Yoshino, Shigetoshi Yoshida, et al.
Molecular Oncology|October 21, 2023
NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT studySatoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, et al.
Scientific Reports|August 2, 2024
CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapyMoto Yaga, Kana Hasegawa, Shunya Ikeda, et al.
Pageof 17

Showing results (161-170 of 166) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 166 results.
The American Journal of Surgical Pathology|March 23, 2022
Thymic Mucoepidermoid Carcinoma: A Clinicopathologic and Molecular StudyTakayuki Murase, Satsuki Nakano, Tadashi Sakane, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 24, 2023
Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607LTomohiro Maniwa, Jiro Okami, Tomohiro Miyoshi, et al.
The Lancet. Respiratory Medicine|March 9, 2023
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trialKeiju Aokage, Kenji Suzuki, Hisashi Saji, et al.
Respiratory Research|July 25, 2016
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)Takekazu Iwata, Ichiro Yoshino, Shigetoshi Yoshida, et al.
Molecular Oncology|October 21, 2023
NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT studySatoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, et al.
Scientific Reports|August 2, 2024
CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapyMoto Yaga, Kana Hasegawa, Shunya Ikeda, et al.
Pageof 17